We are pleased and excited to announce that Michelle McGuinness has joined NGT BioPharma Consultants as VP Regulatory Strategy & Submissions, and head of our Regulatory Affairs practice.
Michelle brings years of Regulatory experience in the biopharmaceutical industry and a passion for drug development that has led to a highly successful career consulting to some of the top companies in the industry.
Among her accomplishments, Michelle was awarded the FDA Commissioner’s Special Citation for her contributions to the HL7 Structured Product Labeling standard & FDA guidance.
You can read more about Michelle’s expertise by clicking here.
